Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.
about
Rivastigmine for Alzheimer's diseaseRivastigmine for Alzheimer's diseaseRivastigmine for Alzheimer's diseaseTreatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study.Current and future treatments for Alzheimer's diseaseRivastigmine for subcortical vascular dementia.Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.Present and prospective clinical therapeutic regimens for Alzheimer's disease.Rivastigmine in the treatment of Alzheimer's disease: an update.Potent beta-amyloid modulators.Zingipain, a ginger protease with acetylcholinesterase inhibitory activity.
P2860
Q24186551-AD0F239A-D895-4EFF-9B69-D7C12112086FQ24187067-B1A67A80-C6F3-4BAE-B0A2-23A104844F92Q24241686-B340CD95-EED5-4A0D-89C9-635E4D7F23DAQ34629649-0420ACAE-E10F-41F3-86F8-E91F9431E1F6Q34646921-B43CEBAF-F988-4D60-A545-901DA9F0B8F7Q36153360-F40FBE4D-D5C1-4696-A7EB-E67FC73382ABQ36475090-2DDBCF3B-0E72-45F8-A24C-7FCD0C3D75DCQ36846711-7A28B740-18FF-48BD-A709-45784D113B2DQ36876447-EFA73064-6078-44A3-B511-5D2B0B8B65C9Q37017260-4D4E2666-489C-42F3-A080-DA7240AA6662Q37103011-429475D3-15D5-4D15-917A-31D3D89AA5DBQ44915865-A9D72280-C51E-4B5B-9F08-0BBB19830E15
P2860
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Preserved cognitive function a ...... untreated AD and MCI patients.
@en
Preserved cognitive function a ...... untreated AD and MCI patients.
@nl
type
label
Preserved cognitive function a ...... untreated AD and MCI patients.
@en
Preserved cognitive function a ...... untreated AD and MCI patients.
@nl
prefLabel
Preserved cognitive function a ...... untreated AD and MCI patients.
@en
Preserved cognitive function a ...... untreated AD and MCI patients.
@nl
P2860
P50
P1476
Preserved cognitive function a ...... untreated AD and MCI patients
@en
P2093
E Stefanova
P2860
P304
P356
10.1046/J.1468-1331.2003.00757.X
P577
2004-04-01T00:00:00Z